Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.8%
Mon, 7 Oct 10:49

ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.8%Image source: KanawatTH/www.istockphoto.com

ALEMBIC PHARMA share price has plunged 5% and is presently trading at Rs 1,181.9.

Meanwhile, the BSE HEALTHCARE index is at 43,227.3 (down 0.8%).

Among the top losers in the BSE HEALTHCARE index today are GSK Pharma (down 4.2%) and Jubilant Pharmova (down 3.9%).

ASTRAZENECA PHARMA (up 7.2%) and Natco Pharma (up 1.4%) are among the top gainers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 790.9 to Rs 1,181.9, registering a gain of Rs 391.0 (up 49.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,227.3, registering a gain of 52.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 146.1%), SUVEN PHARMACEUTICALS (up 101.3%) and Glenmark Pharma (up 98.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,726.4 .

The top gainers among the BSE Sensex today are ITC (up 1.7%) and ICICI Bank (up 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and Bharti Airtel.

In the meantime, NSE Nifty is at 24,972.4 (down 0.2%). MUNDRA PORT & SEZ and ONGC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 81,726.4, registering a gain of 16,214.3 points (up 24.8%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 11.3% YoY to Rs 1,342 million for the quarter ended June 2024, compared to a profit of Rs 1,206 million a year ago. Net sales rose 5.1% to Rs 15,617 million during the period as against Rs 14,862 million in April-June 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 36.9.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Plunges 5%; BSE HEALTHCARE Index Down 0.8%". Click here!